Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Gattinoni

Showing results (81-90 of 118) with videos related to

Pageof 12
Sort By:
Nature Medicine|September 20, 2011
A human memory T cell subset with stem cell-like propertiesLuca Gattinoni, Enrico Lugli, Yun Ji, et al.
Blood|March 21, 2008
Tumor-specific Th17-polarized cells eradicate large established melanomaPawel Muranski, Andrea Boni, Paul A Antony, et al.
Cell|August 28, 2016
Oxygen Sensing by T Cells Establishes an Immunologically Tolerant Metastatic NicheDavid Clever, Rahul Roychoudhuri, Michael G Constantinides, et al.
Immunity|April 23, 2013
MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancerJan C Dudda, Bruno Salaun, Yun Ji, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 25, 2007
T-cell receptor gene therapy of established tumors in a murine melanoma modelJohn D Abad, Claudia Wrzensinski, Willem Overwijk, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2009
Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunityChristian S Hinrichs, Zachary A Borman, Lydie Cassard, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2020
Lactate dehydrogenase inhibition synergizes with IL-21 to promote CD8<sup>+</sup> T cell stemness and antitumor immunityDalton Hermans, Sanjivan Gautam, Juan C García-Cañaveras, et al.
Blood|October 26, 2010
Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapyChristian S Hinrichs, Zachary A Borman, Luca Gattinoni, et al.
Nature Communications|August 27, 2024
LSD1 inhibition improves efficacy of adoptive T cell therapy by enhancing CD8<sup>+</sup> T cell responsivenessIsabella Pallavicini, Teresa Maria Frasconi, Carlotta Catozzi, et al.
The Journal of Clinical Investigation|January 30, 2019
T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapyTori N Yamamoto, Ping-Hsien Lee, Suman K Vodnala, et al.
Pageof 12

Showing results (81-90 of 118) with videos related to

Sort By:
Pageof 12
Nature Medicine|September 20, 2011
A human memory T cell subset with stem cell-like propertiesLuca Gattinoni, Enrico Lugli, Yun Ji, et al.
Blood|March 21, 2008
Tumor-specific Th17-polarized cells eradicate large established melanomaPawel Muranski, Andrea Boni, Paul A Antony, et al.
Cell|August 28, 2016
Oxygen Sensing by T Cells Establishes an Immunologically Tolerant Metastatic NicheDavid Clever, Rahul Roychoudhuri, Michael G Constantinides, et al.
Immunity|April 23, 2013
MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancerJan C Dudda, Bruno Salaun, Yun Ji, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 25, 2007
T-cell receptor gene therapy of established tumors in a murine melanoma modelJohn D Abad, Claudia Wrzensinski, Willem Overwijk, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2009
Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunityChristian S Hinrichs, Zachary A Borman, Lydie Cassard, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2020
Lactate dehydrogenase inhibition synergizes with IL-21 to promote CD8<sup>+</sup> T cell stemness and antitumor immunityDalton Hermans, Sanjivan Gautam, Juan C García-Cañaveras, et al.
Blood|October 26, 2010
Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapyChristian S Hinrichs, Zachary A Borman, Luca Gattinoni, et al.
Nature Communications|August 27, 2024
LSD1 inhibition improves efficacy of adoptive T cell therapy by enhancing CD8<sup>+</sup> T cell responsivenessIsabella Pallavicini, Teresa Maria Frasconi, Carlotta Catozzi, et al.
The Journal of Clinical Investigation|January 30, 2019
T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapyTori N Yamamoto, Ping-Hsien Lee, Suman K Vodnala, et al.
Pageof 12